🔗 Share this article Daily Slimming Pill May Help Cut Body Weight by 20%, Study Shows An everyday weight loss pill may assist individuals cut their body weight by up to a fifth, as per a study that could pave the way for millions more individuals to shed pounds. How the Drug Functions This medication, called the oral treatment, targets the same GLP-1 pathways as slimming injections like tirzepatide and semaglutide. During research of 3,127 participants, one in five people who used the once-a-day pill for more than a year lost 20% or more of their body weight. Slimming injections are transformative, but pill versions are seen as a major breakthrough because they are easier to keep, distribute and take, and may also be projected to be more affordable, providing fresh hope for millions trying to reduce weight. The medication is a GLP-1 stimulant, a type of drug that helps lowering blood sugar levels, slows the digestion of meals and may curb appetite. Trial Findings and Accessibility The weight loss observed in participants using the tablet is not as stark as those in users taking injectable alternatives, but specialists believe the tablet is easier to obtain and user-friendly than shots. Orforglipron has not been authorized by the US Food and Drug Administration or health authorities in other countries. Developers stated it anticipates significant demand once the new pill is launched. In the study, the 3,127 patients were split into cohorts taking orforglipron tablets of different strengths, while some took a dummy pill, for 72 weeks. All of the volunteers were diagnosed with obesity, indicating they had a BMI reading of 30 or over, but they did not have high blood sugar. Patients from multiple nations were involved in the research. Significant Results Scientists discovered that after 72 weeks people taking the lowest dose reduced an mean of nearly 8% of their weight. Participants on the highest dose shed an mean of over 11% of their weight. Among patients taking the highest doses, 54.6% had a reduction of at least 10% of weight, 36% had a loss of 15% or more, and almost one-fifth had a reduction of 20% or more. Researchers said other health metrics additionally got better among people taking the drug, such as better blood pressure, a smaller waist circumference and a reduction in bad cholesterol. The most common adverse reactions were stomach-related, which were described as manageable. “Among participants with obesity, 72-week treatment using orforglipron led to significantly greater reductions in weight than placebo,” researchers wrote. Potential Impact Medical leaders have hailed slimming drugs as game-changing. But shots involve additional work for medical systems, so tablet forms could help millions more people trying to lose weight. Separate studies shows slimming injections may be successful on children as young as age six who have obesity or have diabetes. However, digestive issues were reported more frequently among children using the drugs. They said that extended observation durations in future trials and additional real-world analysis were “essential to determine the long-term effects.”